Grandeur Peak Global Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-58,820
Closed -$1.91M 114
2022
Q3
$1.91M Sell
58,820
-39,640
-40% -$1.63M 0.12% 74
2022
Q2
$3.88M Buy
98,460
+8,303
+9% +$444K 0.24% 60
2022
Q1
$6.3M Buy
90,157
+15,526
+21% +$1.13M 0.3% 65
2021
Q4
$5.81M Buy
74,631
+6,803
+10% +$600K 0.26% 60
2021
Q3
$6.47M Buy
67,828
+15,695
+30% +$1.66M 0.31% 58
2021
Q2
$6.48M Buy
52,133
+19,500
+60% +$2.33M 0.31% 56
2021
Q1
$4.3M Buy
32,633
+8,750
+37% +$1.2M 0.23% 65
2020
Q4
$3.16M Buy
23,883
+2,150
+10% +$260K 0.18% 71
2020
Q3
$2.22M Buy
21,733
+16,608
+324% +$1.43M 0.15% 76
2020
Q2
$446K Buy
5,125
+4,825
+1,608% +$386K 0.03% 96
2020
Q1
$17K Buy
+300
New +$24.4K ﹤0.01% 112
2014
Q4
Sell
-45,350
Closed -$879K 107
2014
Q3
$879K Sell
45,350
-8,900
-16% -$163K 0.21% 77
2014
Q2
$924K Buy
54,250
+26,600
+96% +$366K 0.2% 81
2014
Q1
$392K Buy
27,650
+18,700
+209% +$253K 0.09% 77
2013
Q4
$105K Buy
8,950
+7,000
+359% +$80.3K 0.03% 95
2013
Q3
$23K Buy
1,950
+1,450
+290% +$18.6K 0.01% 131
2013
Q2
$7K Buy
+500
New +$5.43K ﹤0.01% 115

Other funds holding EXAS

Grandeur Peak Global Advisors's EXAS Position: Q4 2022 in Review

Grandeur Peak Global Advisors sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 58,820 shares — an estimated $1.91M sold.

Grandeur Peak Global Advisors first reported a position in EXAS in Q2 2013 and held it in 17 quarters. The position peaked at $6.48M in Q2 2021. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Grandeur Peak Global Advisors reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 58,820 Exact Sciences shares in Q4 2022, an estimated $1.91M.
  • Grandeur Peak Global Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 17 quarters.
  • Grandeur Peak Global Advisors's Exact Sciences position peaked at $6.48M in Q2 2021.
  • 552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Grandeur Peak Global Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.